Boca Raton, FL -- (SBWIRE) -- 10/21/2013 -- StockFreak scours the market on a daily basis looking for the hottest penny stocks that may be the next big runners. StockFreak focuses on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks - ParkerVision, Inc. (NASDAQ:PRKR), Youku Tudou Inc (ADR ) (NYSE:YOKU), athenahealth, Inc (NASDAQ:ATHN), Anacor Pharmaceuticals Inc (NASDAQ:ANAC)
ParkerVision, Inc. (NASDAQ:PRKR) ended higher +17.68% and complete the day at $6.39. The total number of shares changed hands during the day was 17.38 million. After opening at $5.56, the stock hit as high as $7.20. However, it traded between $1.48 and $7.20 over the last twelve months. ParkerVision, Inc. designs, develops, and markets proprietary radio frequency (RF) technologies and products for use in semiconductor circuits for wireless communication products in the United States.
For How Long PRKR will Fight for Profitability? Read This Trend Analysis report
Youku Tudou Inc (ADR ) (NYSE:YOKU) closed yesterday at $30.09, a +7.27% increase. Around 5.34 million shares were traded, beating an-average trading volume of 3.97 million shares. The company is now valued at around $5.60 billion. Youku Tudou Inc. operates as an Internet television company in the People?s Republic of China. Its Internet television platform enables consumers to search, view, and share video content across various devices.
For How Long YOKU’s Gloss will Attract Investors? Find out via this report
athenahealth, Inc (NASDAQ:ATHN) moved +24.05 percent higher at $130.83 and traded between $117.28 and $132.48 after opening the day at $117.46. Its performance over the last five days remained +19.49%, which stands at +15.26% for a month. Going back further than one month, 1-year performance after recent close was +78.51%. athenahealth, Inc., a business services company, provides ongoing billing, clinical-related, and other related services to medical group practices primarily in the United States. The company provides services through the athenaNet, a proprietary Internet-based practice management application.
For How Long ATHN’s Gloss will Attract Investors? Find out via this report
Anacor Pharmaceuticals Inc (NASDAQ:ANAC)’s shares rose, +28.41 percent to close at $13.83. The stock is up around +165.96% this year and +130.12% for the last 12 months. Around 2.71 million shares changed hands yesterday, higher from an-average trading volume of 349,579 shares. Anacor Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform.
Why Should Investors Buy ANAC After The Recent Gain? Just Go Here and Find Out
StockFreak scours the market on a daily basis looking for the hottest penny stocks that may be the next big runners. We strive to provide you with only the most opportunistic picks by pouring over mountains of data and charts. How often we send out our alerts is dependent on how often we find something worthwhile.
GENERAL NOTICE AND DISCLAIMER - PLEASE READ CAREFULLY THE FOLLOWING NOTICE AND DISCLAIMER MUST BE READ AND UNDERSTOOD AND YOU MUST AGREE TO THE TERMS CONTAINED THEREIN BEFORE USING THIS WEBSITE OR SUBSCRIBING TO OUR NEWSLETTER.
We are engaged in the business of advertising and promoting companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. Neither the owner of StockFreak.com nor any of its members, officers, directors, contractors or employees are licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed on StockFreak.com. It is possible that a viewer's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. StockFreak.com makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website.
StockFreak.com has been retained by an unrelated third party to perform promotional and advertising services for a limited time with respect to the company we are profiling or discussing on this website and in exchange for such services has received cash compensation from such third party. Questions regarding this website may be sent to info@StockFreak.com.
Read Our Disclaimer at: http://www.stockfreak.com/disclaimer.html
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)